Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Nephrology

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5414/CNP73276PMID 20353735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of activated vitamin D treatment and mortality in chronic kidney disease.

  2008cited by this paper
• Development of a standard reference material for vitamin D in serum.

  2008cited by this paper
• 25-hydroxyvitamin D levels and the risk of mortality in the general population.

  2008cited by this paper
• Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.

  2008cited by this paper
• Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.

  2007cited by this paper
• Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease

  2007influential reference
• Prevalence of Vitamin D Deficiency and the Safety and Effectiveness of Monthly Ergocalciferol in Hemodialysis Patients

  2007cited by this paper
• Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.

  2007influential reference
• Vitamin D deficiency.

  2007influential reference
• Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

  2007influential reference
• Vitamin D status predicts physical performance and its decline in older persons.

  2007cited by this paper
• Low vitamin D status despite abundant sun exposure.

  2007cited by this paper
• 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.

  2006cited by this paper
• Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.

  2006cited by this paper
• Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.

  2006cited by this paper
• Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.

  2006cited by this paper
• Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays

  2006cited by this paper
• Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis.

  2006cited by this paper
• Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25‐hydroxyvitamin D in chronic kidney disease

  2006cited by this paper
• Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.

  2006cited by this paper
• Mortality risk among hemodialysis patients receiving different vitamin D analogs.

  2006cited by this paper
• The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease.

  2006cited by this paper
• Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

  2005cited by this paper
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

  2005cited by this paper
• Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.

  2005cited by this paper
• Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.

  2005cited by this paper
• Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.

  2005cited by this paper
• Prevalence and Correction of 25(OH) Vitamin D Deficiency in Peritoneal Dialysis Patients

  2005cited by this paper
• Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease

  2004cited by this paper
• Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.

  2004cited by this paper
• Vitamin D2 is much less effective than vitamin D3 in humans.

  2004cited by this paper
• Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases

  2003cited by this paper
• K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

  2003cited by this paper
• An International Comparison of Serum 25-Hydroxyvitamin D Measurements

  1999cited by this paper
• Secondary Hyperparathyroidism in the Elderly: Means to Defining Hypovitaminosis D

  1998cited by this paper
• Hypovitaminosis D in medical inpatients.

  1998cited by this paper
• Calcitriol and calcium carbonate therapy in early chronic renal failure.

  1994cited by this paper
• Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

  1992cited by this paper
• Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women

  1989cited by this paper
• Low dose calcitriol versus placebo in patients with predialysis chronic renal failure.

  1988cited by this paper
• Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.

  1986cited by this paper
• Third national health and nutrition examination survey

  1985cited by this paper
• An equilibrium and kinetic study of 1,25-dihydroxyvitamin D3 binding to chicken intestinal cytosol employing high specific activity 1,25-dehydroxy[3H-26, 27] vitamin D3.

  1979cited by this paper
• 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. I. Association of 1 alpha,25-dihydroxycholecalciferol with intestinal mucosa chromatin.

  1974cited by this paper
• 1α,25-Dihydroxycholecalciferol Receptors in Intestine I. ASSOCIATION OF 1α,25-DIHYDROXYCHOLECALCIFEROL WITH INTESTINAL MUCOSA CHROMATIN

  1974cited by this paper

• Efficacy of high versus conventional dose of ergocalciferol supplementation on serum 25‐hydroxyvitamin D and interleukin‐6 levels among hemodialysis patients with vitamin D deficiency: A multicenter, randomized, controlled study

  2021influential citation
• Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients

  2021cites this paper
• Efficacy of Weekly Split versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Trial

  2021cites this paper
• The frequency of vitamin D deficiency in chronic kidney disease and its relation with baseline mineral bone markers.

  2020cites this paper
• The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.

  2019cites this paper
• The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3–4 CKD

  2019cites this paper
• Native vitamin D in pre-dialysis chronic kidney disease.

  2019cites this paper
• Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial

  2016cites this paper
• Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low

  2016cites this paper
• Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

  2015cites this paper
• Place de la vitamine D native en dialyse

  2015cites this paper
• [Native vitamin D in dialysis patients].

  2015cites this paper
• Weekly high‐dose ergocalciferol to correct vitamin D deficiency/insufficiency in hemodialysis patients: A pilot trial

  2015cites this paper
• Efectos pleiotrópicos del tratamiento combinado con colecalciferol-carbonato cálcico sobre microalbuminuria y proteinuria en pacientes con enfermedad renal crónica estadio IIIb-IV

  2014cites this paper
• Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach

  2014cites this paper
• Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.

  2014cites this paper
• The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients’ with low vitamin D

  2014cites this paper
• The Effect of Calcium With or Without Calcitriol Supplementation on Renal Function in Patients With Hypovitaminosis D and Chronic Kidney Disease

  2014cites this paper
• A Narrow-Band Ultraviolet B Course Improves Vitamin D Balance and Alters Cutaneous CYP27A1 and CYP27B1 mRNA Expression Levels in Haemodialysis Patients Supplemented with Oral Vitamin D

  2013cites this paper
• Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.

  2013cites this paper
• Vitamin D and Kidney

  2013cites this paper
• Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study.

  2013cites this paper
• Significant Independent Predictors of Vitamin D Deficiency in Inpatients and Outpatients of a Nephrology Unit

  2013cites this paper
• High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.

  2012cites this paper
• Vitamin D supplementation in pre-dialysis chronic kidney disease

  2012influential citation
• Cholecalciferol Supplementation in Chronic Kidney Disease: Restoration of Vitamin D Status and Impact on Parathyroid Hormone

  2012cites this paper
• 25-Hydroxyvitamin D Status Based on Estimated Glomerular Filtration Rate in Patients with Chronic Kidney Disease

  2012cites this paper
• The Effect of Vitamin D3 Supplementation on Physical Performance in Ambulatory Patients on Hemodialysis

  2012cites this paper
• © 2012 Landes Bioscience. Do not distribute. Vitamin D supplementation in pre-dialysis chronic kidney disease A systematic review

  2012cites this paper
• Narrow-band ultraviolet B exposure increases serum vitamin D levels in haemodialysis patients.

  2012cites this paper
• Vitamin status and needs for people with stages 3-5 chronic kidney disease.

  2011cites this paper